Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Quality of Life After Radiofrequency Ablation of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy of Ferric Carboxymaltose (Ferinject®) in Anemic Patients Anticipating Pancreatoduodenectomy
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of MGD009 in B7-H3-expressing Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Preoperative Nutritional Support in Malnutritional Cancer Patients
- Status
- COMPLETED
- Phase
- NA
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas
- Status
- RECRUITING
- Phase
- PHASE2
Study of Neo-adjuvant RO7009789 Alone or Neo-adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine Followed by Adjuvant RO7009789 Plus Nab-Paclitaxel and Gemcitabine for Patients With Newly Diagnosed Resectable Pancreatic Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Prospective Phase I Study of GAX for Metastatic Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
- Status
- UNKNOWN
- Phase
- PHASE1
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
- Status
- TERMINATED
- Phase
- N/A
FOLFOX-A For Locally Advanced Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
- Status
- TERMINATED
- Phase
- PHASE1
TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2